ConductScience.org, home

Paper41365876

Identification and targeting oxidative phosphorylation/glycolysis to overcome anti-CSF-1R therapy resistance in glioblastoma.

Miao C and 8 others. Cell Death Dis, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Identification and targeting oxidative phosphorylation/glycolysis to overcome anti-CSF-1R therapy resistance in glioblastoma. Papers, record 41365876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41365876

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identification and targeting oxidative phosphorylation/glycolysis to overcome anti-CSF-1R therapy resistance in glioblastoma.
PubMed
Journal
Cell Death Dis
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-01-26
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miao CChenghttps://orcid.org/0009-0004-6504-1695
2Ding ZZehua
3Wu JJiaxing
4An QQi
5Shu YYa
6Jiang HHaifeng
7Gao PPanpan
8Chen RRuoqiaohttps://orcid.org/0000-0001-9797-1046
9Chen XQXiao Qianhttps://orcid.org/0000-0002-2673-2977

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlioblastomaMajor topic
Drug Resistance, NeoplasmMajor topic
Oxidative PhosphorylationMajor topic
Brain NeoplasmsMajor topic
Receptors, Granulocyte-Macrophage Colony-Stimulating FactorMajor topic
Animals
Mice
Humans
Temozolomide
Cell Line, Tumor

Source PubMed

Download CSV of topics

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134696786Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34696786PubMed
233252849Mannose synergizes with chemoradiotherapy to cure cancer via metabolically targeting HIF-1 in a novel triple-negative glioblastoma mouse model.Clin Transl Med2020https://conductscience.org/library/papers/33252849PubMed
327104977On the Dependency of Cellular Protein Levels on mRNA Abundance.Cell2016https://conductscience.org/library/papers/27104977PubMed
434950148The Colony Stimulating Factor-1 Receptor (CSF-1R)-Mediated Regulation of Microglia/Macrophages as a Target for Neurological Disorders (Glioma, Stroke).Front Immunol2021https://conductscience.org/library/papers/34950148PubMed
531850228The Binding of PD-L1 and Akt Facilitates Glioma Cell Invasion Upon Starvation via Akt/Autophagy/F-Actin Signaling.Front Oncol2019https://conductscience.org/library/papers/31850228PubMed
623227453Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma.Front Oncol2012https://conductscience.org/library/papers/23227453PubMed
737987212Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems-level property in cancer.Cancer Med2023https://conductscience.org/library/papers/37987212PubMed
834562087Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition.Neuro Oncol2022https://conductscience.org/library/papers/34562087PubMed
927068937Role of the colony-stimulating factor (CSF)/CSF-1 receptor axis in cancer.Biochem Soc Trans2016https://conductscience.org/library/papers/27068937PubMed
1038751936Next generation sequencing technologies to address aberrant mRNA translation in cancer.NAR Cancer2024https://conductscience.org/library/papers/38751936PubMed
1139905019CDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance.Cell Death Dis2025https://conductscience.org/library/papers/39905019PubMed
1232440095Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.Drug Des Devel Ther2020https://conductscience.org/library/papers/32440095PubMed
1329416029Neuroglobin boosts axon regeneration during ischemic reperfusion via p38 binding and activation depending on oxygen signal.Cell Death Dis2018https://conductscience.org/library/papers/29416029PubMed
1439744695A molecularly distinct cell type in the midbrain regulates intermale aggression behaviors in mice.Theranostics2025https://conductscience.org/library/papers/39744695PubMed
1524810037Cell type-specific mRNA purification by translating ribosome affinity purification (TRAP).Nat Protoc2014https://conductscience.org/library/papers/24810037PubMed
1636230833
The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma.
Cancers (Basel)2022https://conductscience.org/library/papers/36230833PubMed
1738002561Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings.Brain Sci2023https://conductscience.org/library/papers/38002561PubMed
1828514441PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.Nature2017https://conductscience.org/library/papers/28514441PubMed
1931530089Diversity, Mechanisms, and Significance of Macrophage Plasticity.Annu Rev Pathol2020https://conductscience.org/library/papers/31530089PubMed
2038216766Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial.Nat Cancer2024https://conductscience.org/library/papers/38216766PubMed

See all 61 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42891212Beyond M1 M2: single-cell insights into how glioblastoma reshapes tumour-associated macrophages.Front Immunol2026https://conductscience.org/library/papers/42891212PubMed
42732341Tissue-Resident Macrophage in Inflammation and Cancer.MedComm (2020)2026https://conductscience.org/library/papers/42732341PubMed
42483730GSTM3 Knockdown Promotes Liver Fibrosis Reversal by Inhibiting Hepatic Stellate Cell Activation via PPARγ Signaling.J Clin Transl Hepatol2026https://conductscience.org/library/papers/42483730PubMed
42389513Epstein-Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics.Front Immunol2026https://conductscience.org/library/papers/42389513PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41365876

GET https://conductscience.org/api/papers/v1/41365876/references?page=2